| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 150.006 | 80 |
| GSM780708 | Untreated after 4 days (C2_1) | 127.801 | 78 |
| GSM780709 | Untreated after 4 days (C3_1) | 123.464 | 78 |
| GSM780719 | Untreated after 4 days (C1_2) | 133.828 | 79 |
| GSM780720 | Untreated after 4 days (C2_2) | 114.183 | 77 |
| GSM780721 | Untreated after 4 days (C3_2) | 120.597 | 78 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 120.785 | 78 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 141.295 | 80 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 130.21 | 79 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 157.66 | 81 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 146.952 | 80 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 124.906 | 78 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 153.899 | 81 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 113.136 | 77 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 128.071 | 79 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 184.34 | 83 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 126.274 | 78 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 155.695 | 81 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 116.28 | 77 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 145.961 | 80 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 154.431 | 81 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 134.62 | 79 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 155.255 | 81 |